Korea United Pharm Inc. (KRX:033270)
South Korea · Delayed Price · Currency is KRW 19,190
-200 (-1.03%)
Last updated: Nov 5, 2025, 3:04 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 282.78 billion as of November 5, 2025. Its market cap has decreased by -7.59% in one year.
Market Cap
282.78B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
15.24
Stock Price
19,190.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 282.78B, an increase of 726.43%. That is a compound annual growth rate of 8.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 282.78B | 5.56% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | 1.03T | 262.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 9.01T |
| HLB Co., Ltd. | 7.03T |
| Peptron | 6.14T |
| ABL Bio | 6.13T |